Adjuvant modulation of immune responses to tuberculosis subunit vaccines.
about
Host immune responses to mycobacterial antigens and their implications for the development of a vaccine to control tuberculosisAdjuvants for peptide-based cancer vaccinesInterleukin-6 regulates the phenotype of the immune response to a tuberculosis subunit vaccineThe adjuvant mechanism of cationic dimethyldioctadecylammonium liposomes.Structure-activity relationship of immunostimulatory effects of phthalatesGamma interferon and monophosphoryl lipid A-trehalose dicorynomycolate are efficient adjuvants for Mycobacterium tuberculosis multivalent acellular vaccine.Tuberculosis DNA vaccine encoding Ag85A is immunogenic and protective when administered by intramuscular needle injection but not by epidermal gene gun bombardment.A randomized trial of a standard dose of Edmonston-Zagreb measles vaccine given at 4.5 months of age: effect on total hospital admissionsEffective, nonsensitizing vaccination with culture filtrate proteins against virulent Mycobacterium bovis infections in mice.Acquired resistance but not innate resistance to Mycobacterium bovis bacillus Calmette-Guérin is compromised by interleukin-12 ablationImmunization of cats against feline immunodeficiency virus (FIV) infection by using minimalistic immunogenic defined gene expression vector vaccines expressing FIV gp140 alone or with feline interleukin-12 (IL-12), IL-16, or a CpG motif.Protection against Leptospira interrogans sensu lato challenge by DNA immunization with the gene encoding hemolysin-associated protein 1.Lack of humoral immune protection against Treponema denticola virulence in a murine modelInterleukin-6 and interleukin-12 participate in induction of a type 1 protective T-cell response during vaccination with a tuberculosis subunit vaccine.T-cell recognition of Mycobacterium tuberculosis culture filtrate fractions in tuberculosis patients and their household contacts.ESAT-6 subunit vaccination against Mycobacterium tuberculosisAntigen specificity of T-cell response to Mycobacterium avium infection in mice.Oral vaccination with subunit vaccines protects animals against aerosol infection with Mycobacterium tuberculosisNon-specific effects of standard measles vaccine at 4.5 and 9 months of age on childhood mortality: randomised controlled trialTesting the hypothesis that diphtheria-tetanus-pertussis vaccine has negative non-specific and sex-differential effects on child survival in high-mortality countriesMapping of murine Th1 helper T-Cell epitopes of mycolyl transferases Ag85A, Ag85B, and Ag85C from Mycobacterium tuberculosis.High frequency of CD4+ T cells specific for the TB10.4 protein correlates with protection against Mycobacterium tuberculosis infection.Virulence, immunogenicity, and protective efficacy of two recombinant Mycobacterium bovis bacillus Calmette-Guérin strains expressing the antigen ESAT-6 from Mycobacterium tuberculosis.Enhanced immunogenicity and protective efficacy with the use of interleukin-12-encapsulated microspheres plus AS01B in tuberculosis subunit vaccination.The Mycobacterium tuberculosis recombinant 27-kilodalton lipoprotein induces a strong Th1-type immune response deleterious to protection.IL12B expression is sustained by a heterogenous population of myeloid lineages during tuberculosis.Inactivated Francisella tularensis live vaccine strain protects against respiratory tularemia by intranasal vaccination in an immunoglobulin A-dependent fashion.Immunization with recombinant Sao protein confers protection against Streptococcus suis infection.Interleukin-12 and tuberculosis: an old story revisitedVaccines for tuberculosis: novel concepts and recent progress.Protective efficacy of antigenic fractions in mouse models of cryptococcosis.Combination of the cationic surfactant dimethyl dioctadecyl ammonium bromide and synthetic mycobacterial cord factor as an efficient adjuvant for tuberculosis subunit vaccines.Enhanced protection against bovine tuberculosis after coadministration of Mycobacterium bovis BCG with a Mycobacterial protein vaccine-adjuvant combination but not after coadministration of adjuvant alone.A cell-based microarray to investigate combinatorial effects of microparticle-encapsulated adjuvants on dendritic cell activation.Immunomodulation of TH2 biased immunity with mucosal administration of nanoemulsion adjuvant.Ag85A DNA Vaccine Delivery by Nanoparticles: Influence of the Formulation Characteristics on Immune ResponsesRoutine vaccinations and child survival: follow up study in Guinea-Bissau, West Africa.Mycobacterium tuberculosis culture filtrate proteins plus CpG Oligodeoxynucleotides confer protection to Mycobacterium bovis BCG-primed mice by inhibiting interleukin-4 secretion.Immune Responses to Bacillus Calmette-Guérin Vaccination: Why Do They Fail to Protect against Mycobacterium tuberculosis?Adjuvant modulation of the immune responses and the outcome of infection with Chlamydia pneumoniae.
P2860
Q26863391-94BCB798-C475-416B-83B4-9B98E26C5D36Q28072236-F5386FB4-8DC1-43A4-BE90-ADAFA7223533Q28343879-539B958B-5A1E-4688-A0F8-4ADB4701084BQ33273936-97B298E9-52B2-468F-816E-203E4C6328E1Q33381839-088D1AE6-E59D-4F23-8C72-25B1F7291FF2Q33558303-6A21042F-0173-4AE9-910F-494930657813Q33595922-0619DEE8-168C-4A30-9D95-FA2D78A2E415Q33596061-AF2B828B-BEC9-4D2B-85B9-DBEA110A94E9Q33767136-A79CF6CF-936A-4208-82D7-AF68EAB94347Q33767573-BED8ACFD-CFD5-4312-A3E2-23486941DA4EQ33787237-BF74C239-8615-4596-A063-9968B0FAD30EQ33883383-8E4F9E06-477F-4049-B127-981FD4A5B8F6Q34002375-EC219D20-A515-4894-807D-760ED7EFBF41Q34002381-69539446-4A9C-4919-8269-15DA56E7F712Q34002515-A4DE7654-1CDF-44A0-9E06-EB8E3FA2A1D8Q34003301-6A2DA9C7-60BD-4299-9839-C072E47DAB1AQ34007982-283049AC-9EFB-452A-B3D7-9B6724945473Q34122078-09E7FEBF-700D-4962-B02E-E4D4CA2AF3CAQ34152512-87DA8A34-0005-486E-BF8C-5BAFB843DA21Q34276739-F25678BF-741B-4C9B-92B3-E14302692A3FQ34527217-97C72F0B-227D-458A-8260-109D972D1926Q34681015-28CE2F06-946E-458F-A175-063466EE13AEQ34853792-4D87216C-90A7-43F6-817D-CD1022F79E8CQ34975671-7E5DDDC8-C008-46F1-8BB0-7B4AE49EC57FQ35011298-CB46D898-2067-49E2-8263-49D8EC82ED53Q35551021-EC93C35A-7F95-45AD-A5B3-C55B5851FDEFQ35784151-353EF9B8-605E-4827-B408-4BCF44D37350Q36097153-4073778D-CD36-4945-94DD-2F10FAA5EB20Q36137298-6C0C0D51-7C2D-44CC-A28F-39A876D38C22Q36285657-AA4FC0AB-306D-47DD-A077-617CC31A9FCEQ36576482-67740EE7-5A34-488A-86A9-9F542AECA772Q36576750-5C79EECC-7D19-4ED9-BE98-BEB505AB3368Q36672533-324F9C3F-1C65-451E-9E9B-9274230072FBQ36684447-E1B1E3E1-7A88-4ACC-BD8D-530F40C0F0BAQ37130834-9EE6CE03-5733-467A-A282-E4C983ACD794Q37293872-573DA5E2-FB69-4B36-AFAC-37FDDFC07715Q37368507-ED8D7A35-ACF9-47ED-BA1C-571CF09F9F03Q37451207-BE7ABBEE-0E7F-4175-A4FC-01667F970998Q37737607-94265E4E-B234-4C72-B96C-5A0703F3B5DEQ37870760-8B306B94-FF8F-4726-B952-7C128308FB48
P2860
Adjuvant modulation of immune responses to tuberculosis subunit vaccines.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Adjuvant modulation of immune responses to tuberculosis subunit vaccines.
@ast
Adjuvant modulation of immune responses to tuberculosis subunit vaccines.
@en
type
label
Adjuvant modulation of immune responses to tuberculosis subunit vaccines.
@ast
Adjuvant modulation of immune responses to tuberculosis subunit vaccines.
@en
prefLabel
Adjuvant modulation of immune responses to tuberculosis subunit vaccines.
@ast
Adjuvant modulation of immune responses to tuberculosis subunit vaccines.
@en
P2093
P2860
P1476
Adjuvant modulation of immune responses to tuberculosis subunit vaccines
@en
P2093
P2860
P304
P407
P577
1997-02-01T00:00:00Z